Home > Boards > US Listed > Biotechs > iBio, Inc. (IBIO)

$IBIO DD Notes ~ http://www.ddnotesmaker.com/IBIO

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
stocktrademan Member Profile
Followed By 476
Posts 10,152
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/13/2021 4:07:16 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/28/2021 4:13:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/27/2021 5:31:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 7:46:16 AM
iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 9/27/2021 7:30:00 AM
iBio to Participate in the Cantor 2021 Virtual Global Healthcare Conference GlobeNewswire Inc. - 9/20/2021 4:30:00 PM
iBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Monday, September 27, 2021 GlobeNewswire Inc. - 9/20/2021 7:30:00 AM
iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire Inc. - 9/7/2021 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/31/2021 4:31:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/26/2021 7:11:29 AM
iBio Appoints William D. Clark to its Board of Directors GlobeNewswire Inc. - 8/26/2021 7:00:00 AM
iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics GlobeNewswire Inc. - 8/25/2021 7:30:00 AM
iBio says successful in preclinical studies for subunit COVID-19 vaccine candidate Seeking Alpha - 7/16/2021 7:24:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/16/2021 6:04:34 AM
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate GlobeNewswire Inc. - 7/15/2021 5:10:00 PM
iBio establishes oncology drug discovery pipeline with three new antibody programs Seeking Alpha - 7/8/2021 4:23:04 PM
iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs GlobeNewswire Inc. - 7/8/2021 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2021 5:20:28 PM
iBio adds veteran biopharmaceutical executive to board of directors Seeking Alpha - 6/9/2021 4:44:08 PM
iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink GlobeNewswire Inc. - 6/9/2021 4:30:00 PM
iBio to Present at the UBS Global Healthcare Virtual Conference GlobeNewswire Inc. - 5/19/2021 4:30:00 PM
iBio Q1 net loss widens as expenses soar year-over-year; shares fall 6% Seeking Alpha - 5/17/2021 10:08:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2021 7:16:10 AM
iBio revenue in-line Seeking Alpha - 5/17/2021 7:04:02 AM
iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 5/17/2021 7:00:00 AM
stocktrademan   Thursday, 10/30/14 12:31:17 PM
Re: None
Post # of 26343 
$IBIO DD Notes ~ http://www.ddnotesmaker.com/IBIO

Topdown market analysis:
Market is _BULLISH_
Today is _UP_
Bullish Sector _BIOTECHNOLOGY_

bullish stock in this sector

$IBIO recent news/filings

## source: finance.yahoo.com

Wed, 29 Oct 2014 22:27:00 GMT ~ Robbins Arroyo LLP: iBio, Inc. (IBIO) Misled Shareholders According to a Recently Filed Class Action

[GlobeNewswire] - SAN DIEGO and NEWARK, Del. -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of iBio, Inc. has filed a federal securities fraud class action complaint in the U.S. District Court ...

read full: http://finance.yahoo.com/news/robbins-arroyo-llp-ibio-inc-222700121.html

Wed, 29 Oct 2014 17:57:32 GMT ~ SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in iBio, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- IBIO

[GlobeNewswire] - STEVENSON, Md. -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District ...

read full: http://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-175732735.html

Wed, 29 Oct 2014 15:45:50 GMT ~ SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against iBio, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 23, 2014 -- IBIO

[GlobeNewswire] - NEW YORK -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" ...

read full: http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-154550057.html

Wed, 29 Oct 2014 00:00:00 GMT ~ Harwood Feffer LLP Announces Investigation of iBio, Inc.

[PR Newswire] - NEW YORK, Oct. 28, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of iBio, Inc. ("iBio" or the "Company") (IBIO), concerning whether the board has breached its fiduciary duties to shareholders. On October 16, 2014, iBio issued a press release purporting to confirm that certain of its patents and proprietary technology could be used in "the further development and production of antibodies that target the Ebola virus." The press release also stated that iBio's partnership with Caliber Biotherapeutics LLC ("Caliber") involved the development of drugs to fight Ebola. The next day, a representative of iBio reportedly stated that the manufacture of experimental Ebola drug, ZMapp, would require a license from iBio. On this news, iBio's stock price increased significantly. On October 20 and 23, 2014, reports were published online revealing that iBio's partnership with Caliber was unrelated to Ebola and that ZMapp could be, and would be, produced without a license from iBio. When the truth was revealed, iBio stock promptly lost more than 50% of its value.

read full: http://finance.yahoo.com/news/harwood-feffer-llp-announces-investigation-000000666.html

Tue, 28 Oct 2014 21:05:00 GMT ~ INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In iBio, Inc. (IBIO) To Contact The Firm

[PR Newswire] - NEW YORK, Oct. 28, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in iBio, Inc. ("iBio" or the "Company") (IBIO) of the December 23, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against iBio and the Company's CEO. A complaint has been filed in the United States District Court for the District of Delaware on behalf of all persons who purchased iBio common stock between October 13, 2014 and October 23, 2014 (the "Class Period"). The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

read full: http://finance.yahoo.com/news/investor-alert-faruqi-faruqi-llp-210500268.html

$IBIO charts

basic chart ## source: stockcharts.com

basic chart ## source: stockscores.com

big daily chart ## source: stockcharts.com

big weekly chart ## source: stockcharts.com

$IBIO company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/IBIO/company-info
Ticker: $IBIO
OTC Market Place: Not Available
CIK code: 0001420720
Company name: iBio Inc.
Incorporated In: DE, USA

Business Description:

$IBIO share structure

## source: otcmarkets.com

Market Value: $64,255,904 a/o Oct 29, 2014
Shares Outstanding: 67,460,267 a/o Sep 26, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$IBIO extra dd links

Company name: iBio Inc.
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=IBIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=IBIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=IBIO+Industry

Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/IBIO/news - http://finance.yahoo.com/q/h?s=IBIO+Headlines

Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/IBIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/IBIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=IBIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/IBIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=iBio+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=iBio+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=iBio+Inc.&x=0&y=0

Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/IBIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001420720&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/IBIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/IBIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=IBIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=IBIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/IBIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=IBIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=IBIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=IBIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=IBIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=IBIO+Cash+Flow&annual

Major holdings (cnbc.com): http://data.cnbc.com/quotes/IBIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=IBIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/IBIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=IBIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/IBIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/IBIO/insider-transactions

PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/IBIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/IBIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/IBIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=IBIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=IBIO

$IBIO DD Notes ~ http://www.ddnotesmaker.com/IBIO

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences